Europlasma SA
PAR:ALEUP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Europlasma SA
PAR:ALEUP
|
FR |
|
Aerovate Therapeutics Inc
NASDAQ:AVTE
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALEUP's stock price target?
Not Available
ALEUP does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Europlasma SA?
Projected CAGR
-20%
Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 8 years is -20%.
What is the Gross Profit forecast for Europlasma SA?
Projected CAGR
-12%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 8 years is -12%.